STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 74 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $73,000 | -54.1% | 15,085 | +0.6% | 0.00% | – |
| Q4 2019 | $159,000 | +3.9% | 14,988 | +2.0% | 0.00% | – |
| Q3 2019 | $153,000 | -7.8% | 14,694 | +33.5% | 0.00% | – |
| Q2 2019 | $166,000 | +39.5% | 11,004 | +18.5% | 0.00% | – |
| Q1 2019 | $119,000 | +72.5% | 9,289 | +28.6% | 0.00% | – |
| Q4 2018 | $69,000 | -36.7% | 7,222 | +10.3% | 0.00% | – |
| Q3 2018 | $109,000 | +21.1% | 6,549 | +16.7% | 0.00% | – |
| Q2 2018 | $90,000 | +9.8% | 5,612 | +4.9% | 0.00% | – |
| Q1 2018 | $82,000 | -90.0% | 5,348 | -89.8% | 0.00% | – |
| Q4 2017 | $817,000 | +8977.8% | 52,343 | +6500.6% | 0.00% | – |
| Q3 2017 | $9,000 | -96.7% | 793 | -96.8% | 0.00% | – |
| Q4 2016 | $269,000 | +896.3% | 25,121 | +909.3% | 0.00% | – |
| Q3 2016 | $27,000 | +8.0% | 2,489 | -32.7% | 0.00% | – |
| Q2 2016 | $25,000 | -99.6% | 3,700 | -97.4% | 0.00% | -100.0% |
| Q3 2013 | $6,470,000 | +32.9% | 142,837 | -30.0% | 0.00% | 0.0% |
| Q2 2013 | $4,867,000 | – | 204,145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|